Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

IBB vs PVAL: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, IBB returned +37.5% to PVAL's +26.6%, and IBB charges 0.44% to PVAL's 0.55%.

askIQ about this page

askIQ about IBB and PVAL

Net assets: $11.0bn on Oct 27, 2026 for iShares Biotechnology ETF, and $14.1bn on Aug 31, 2026 for Putnam Focused Large Cap Value ETF.

At a glance
+37.5%
IBB total return, 1 year
+26.6%
PVAL total return, 1 year
0.44%
IBB expense ratio
0.55%
PVAL expense ratio

Pair scorecard

IBB costs 0.11 points a year less; their one-year returns differ by 10.9 points.

IBB vs PVAL: Differences, Returns & Fees
MeasureIBBPVAL
Return
Total return, 1 year+37.5%+26.6%
Benchmark
What it tracksBiotechNo index, actively managed
Cost and size
Expense ratio0.44%0.55%
Net assets, IBB as of Oct 27, 2026 and PVAL as of Aug 31, 2026$11.0bn$14.1bn
Active share vs the S&P 50099%
Holdings
Holdings in common4%
Top ten holdings, share of the fund50%42.8%

Holdings in common uses holdings dated Aug 31, 2026 and Oct 27, 2026. Method

What they share

4%

By the books each fund has filed, IBB and PVAL hold 4% of their money in the same securities at the same weight. Holdings dated Aug 31, 2026 and Oct 27, 2026.

0 half 100%

half

4% in common

Positions both hold · largest shared weight first IBB PVAL
VERTEX PHARMACEUTICALS 7.53% 2.07%
REGENERON PHARMACEUTICALS 5.64% 1.61%
Only in one fund ↓
Only in IBB
GILEAD SCIENCES 8.56%
AMGEN INC 8.20%
MODERNA 5.29%
NATERA 3.85%
ARGENX SE ADR 3.42%
ILLUMINA INC 2.93%
BIOGEN 2.58%
REVOLUTION MEDICINES 2.50%
Only in PVAL
MICROSOFT CORP 9.27%
APPLE INC 6.70%
AMAZON.COM INC 4.71%
EXXONMOBIL HOLDINGS CORP 3.77%
CHARLES SCHWAB CORP (THE) 3.25%
CITIGROUP INC 3.25%
FREEPORT-MCMORAN INC 3.13%
COCA-COLA COMPANY (THE) 2.95%
Check overlap with more funds →

Side by side

IBB iShares Biotechnology ETF PVAL Putnam Focused Large Cap Value ETF
Where it sits Thematic ETF Stock ETF
What it is Biotech Actively managed
Total return, 1 year +37.5% +26.6%
Its benchmark over the same days not measured +27.5% (IWD)
Gap to its benchmark not measured −0.9 pts vs IWD
Expense ratio 0.44% 0.55%
Already in the S&P 500 40.2% 91.4%
Holdings 245 44
Net assets, IBB as of Oct 27, 2026 and PVAL as of Aug 31, 2026 $11.0bn $14.1bn

IBB and PVAL on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Alert

IBB flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
IBB

By weight, 40% of IBB's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 99%. The top ten holdings are 50% of the fund across 245 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +37.5% with distributions reinvested.

PVAL

Over the year to Oct 28, 2026 it returned +26.6% with distributions reinvested, against +27.5% for its benchmark, the Russell 1000 Value Index.

PVAL is actively managed and tracks no index. The prospectus expense ratio is 0.55% a year. By its holdings filed for Aug 31, 2026, 91% of the fund by weight is stocks the S&P 500 also holds, across 44 positions, with the top ten at 42.8%.

Questions people ask

Are IBB and PVAL in the same category?
IBB is a thematic ETF and PVAL is a stock ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, IBB or PVAL?
In the year to Oct 28, 2026, with distributions reinvested, IBB returned +37.5% and PVAL +26.6%.
Which is cheaper, IBB or PVAL?
IBB is cheaper, by 0.11 percentage points a year. That is about $11 on $10,000 held for a year. Fees come from each fund's prospectus.
How much do IBB and PVAL overlap with the S&P 500?
By their latest filed holdings, 40% of IBB and 91% of PVAL by weight is stocks the S&P 500 already holds.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, IBB against PVAL, data as of Oct 28, 2026. https://etfiq.com/compare/any/ibb-vs-pval

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.